How are CAR-T Cells Revolutionizing Cancer Therapy?
Chimeric Antigen Receptor T-cells (CAR-T cells) represent a groundbreaking approach in cancer immunotherapy. By genetically engineering a patient’s own T-cells to express receptors specific to cancer cells, CAR-T cell therapy enables the immune system to better recognize and destroy malignant cells. This treatment has shown remarkable success in certain types of blood cancers like acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma.